These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 15713257

  • 21. Characterization of cells with proliferative activity after a brain injury.
    Tatsumi K, Haga S, Matsuyoshi H, Inoue M, Manabe T, Makinodan M, Wanaka A.
    Neurochem Int; 2005 Apr; 46(5):381-9. PubMed ID: 15737436
    [Abstract] [Full Text] [Related]

  • 22. Decreased expression of brain-derived neurotrophic factor in BDNF(+/-) mice is associated with enhanced recovery of motor performance and increased neuroblast number following experimental stroke.
    Nygren J, Kokaia M, Wieloch T.
    J Neurosci Res; 2006 Aug 15; 84(3):626-31. PubMed ID: 16770774
    [Abstract] [Full Text] [Related]

  • 23. Circulating NGF antibody alters the distribution of NG2 and CD56 positive cells in the brain of an animal model of inflammatory disorder.
    Triaca V, Tirassa P.
    Arch Ital Biol; 2003 Mar 15; 141(2-3):127-39. PubMed ID: 12825324
    [Abstract] [Full Text] [Related]

  • 24. Therapeutic effects of combined treatment with ribavirin and tiazofurin on experimental autoimmune encephalomyelitis development: clinical and histopathological evaluation.
    Stojkov D, Lavrnja I, Pekovic S, Dacic S, Bjelobaba I, Mostarica-Stojkovic M, Stosic-Grujicic S, Jovanovic S, Nedeljkovic N, Rakic L, Stojiljkovic M.
    J Neurol Sci; 2008 Apr 15; 267(1-2):76-85. PubMed ID: 17996253
    [Abstract] [Full Text] [Related]

  • 25. Enriched environment promotes adult neural progenitor cell mobilization in mouse demyelination models.
    Magalon K, Cantarella C, Monti G, Cayre M, Durbec P.
    Eur J Neurosci; 2007 Feb 15; 25(3):761-71. PubMed ID: 17298600
    [Abstract] [Full Text] [Related]

  • 26. Phenytoin protects central axons in experimental autoimmune encephalomyelitis.
    Black JA, Waxman SG.
    J Neurol Sci; 2008 Nov 15; 274(1-2):57-63. PubMed ID: 18485368
    [Abstract] [Full Text] [Related]

  • 27. Neurological functional recovery after thymosin beta4 treatment in mice with experimental auto encephalomyelitis.
    Zhang J, Zhang ZG, Morris D, Li Y, Roberts C, Elias SB, Chopp M.
    Neuroscience; 2009 Dec 29; 164(4):1887-93. PubMed ID: 19782721
    [Abstract] [Full Text] [Related]

  • 28. GSNO attenuates EAE disease by S-nitrosylation-mediated modulation of endothelial-monocyte interactions.
    Prasad R, Giri S, Nath N, Singh I, Singh AK.
    Glia; 2007 Jan 01; 55(1):65-77. PubMed ID: 17019693
    [Abstract] [Full Text] [Related]

  • 29. Bone marrow stromal cells reduce axonal loss in experimental autoimmune encephalomyelitis mice.
    Zhang J, Li Y, Lu M, Cui Y, Chen J, Noffsinger L, Elias SB, Chopp M.
    J Neurosci Res; 2006 Aug 15; 84(3):587-95. PubMed ID: 16773650
    [Abstract] [Full Text] [Related]

  • 30. Treatment of stroke with erythropoietin enhances neurogenesis and angiogenesis and improves neurological function in rats.
    Wang L, Zhang Z, Wang Y, Zhang R, Chopp M.
    Stroke; 2004 Jul 15; 35(7):1732-7. PubMed ID: 15178821
    [Abstract] [Full Text] [Related]

  • 31. Erythropoietin and GDNF enhance ventral mesencephalic fiber outgrowth and capillary proliferation following neural transplantation in a rodent model of Parkinson's disease.
    McLeod M, Hong M, Mukhida K, Sadi D, Ulalia R, Mendez I.
    Eur J Neurosci; 2006 Jul 15; 24(2):361-70. PubMed ID: 16903847
    [Abstract] [Full Text] [Related]

  • 32. Surgical excision of CNS-draining lymph nodes reduces relapse severity in chronic-relapsing experimental autoimmune encephalomyelitis.
    van Zwam M, Huizinga R, Heijmans N, van Meurs M, Wierenga-Wolf AF, Melief MJ, Hintzen RQ, 't Hart BA, Amor S, Boven LA, Laman JD.
    J Pathol; 2009 Mar 15; 217(4):543-51. PubMed ID: 19023878
    [Abstract] [Full Text] [Related]

  • 33. Exacerbation of experimental autoimmune encephalomyelitis after withdrawal of phenytoin and carbamazepine.
    Black JA, Liu S, Carrithers M, Carrithers LM, Waxman SG.
    Ann Neurol; 2007 Jul 15; 62(1):21-33. PubMed ID: 17654737
    [Abstract] [Full Text] [Related]

  • 34. Olig2-expressing progenitor cells preferentially differentiate into oligodendrocytes in cuprizone-induced demyelinated lesions.
    Islam MS, Tatsumi K, Okuda H, Shiosaka S, Wanaka A.
    Neurochem Int; 2009 Jul 15; 54(3-4):192-8. PubMed ID: 19070638
    [Abstract] [Full Text] [Related]

  • 35. Neuroprotection and immunomodulation with mesenchymal stem cells in chronic experimental autoimmune encephalomyelitis.
    Kassis I, Grigoriadis N, Gowda-Kurkalli B, Mizrachi-Kol R, Ben-Hur T, Slavin S, Abramsky O, Karussis D.
    Arch Neurol; 2008 Jun 15; 65(6):753-61. PubMed ID: 18541795
    [Abstract] [Full Text] [Related]

  • 36. Oral flavonoids delay recovery from experimental autoimmune encephalomyelitis in SJL mice.
    Verbeek R, van Tol EA, van Noort JM.
    Biochem Pharmacol; 2005 Jul 15; 70(2):220-8. PubMed ID: 15946653
    [Abstract] [Full Text] [Related]

  • 37. Targeted expression of IGF-1 in the central nervous system fails to protect mice from experimental autoimmune encephalomyelitis.
    Genoud S, Maricic I, Kumar V, Gage FH.
    J Neuroimmunol; 2005 Nov 15; 168(1-2):40-5. PubMed ID: 16120466
    [Abstract] [Full Text] [Related]

  • 38. Inhibitory effect on cerebral inflammatory agents that accompany traumatic brain injury in a rat model: a potential neuroprotective mechanism of recombinant human erythropoietin (rhEPO).
    Chen G, Shi JX, Hang CH, Xie W, Liu J, Liu X.
    Neurosci Lett; 2007 Oct 02; 425(3):177-82. PubMed ID: 17825990
    [Abstract] [Full Text] [Related]

  • 39. Pretreatment with low doses of erythropoietin ameliorates brain damage in periventricular leukomalacia by targeting late oligodendrocyte progenitors: a rat model.
    Mizuno K, Hida H, Masuda T, Nishino H, Togari H.
    Neonatology; 2008 Oct 02; 94(4):255-66. PubMed ID: 18784421
    [Abstract] [Full Text] [Related]

  • 40. Genistein down-modulates pro-inflammatory cytokines and reverses clinical signs of experimental autoimmune encephalomyelitis.
    De Paula ML, Rodrigues DH, Teixeira HC, Barsante MM, Souza MA, Ferreira AP.
    Int Immunopharmacol; 2008 Sep 02; 8(9):1291-7. PubMed ID: 18602076
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.